MedPath

Effect of Ushiraadi anjana & Dwitiya Triphaladi ghrita pana in Timira(Presbyopia)

Not yet recruiting
Conditions
Presbyopia. Ayurveda Condition: Dwitiya Patalagata Timira,
Registration Number
CTRI/2021/08/035591
Lead Sponsor
Rishikul campus Haridwar UAU
Brief Summary

The Clinical study will be conducted with aim to provide a better treatment approach to patients of Dwitiya Patalagata Timira ( Presbyopia). In this clinical study Ushiraadi Anjana & Dwitiya Triphaladi Ghrita pana will be administered to the patients selected randomly for clinical trial.  Total 40 patients fulfilling the inclusion & exclusion criteria will be registered in a single group for this study from OPD/IPD of P.G department of Shalakya Tantra, Rishikul campus, Haridwar. Uttarakhand Ayurved University.A detailed proforma will be prepared on the basis of Ayurvedic texts & allied science.The scoring of different clinical features will be done on the basis of different assessment criterian.  After completion of 45 days trial, 2 follow ups will be done at intervals of 1 month.The different tables of scores obtained before & after treatment will be prepared for the comparison & statistical analysis will be done by applying suitable tests.The inference will be made on the basis of statistically analysed data.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • 1.Patients presenting with clinical features of Dwitiya patalagata timira(Presbyopia) 2.
  • Patients between age group of 35-55 years 3.
  • Patients having near visual acuity < N6 or N6 with strain 4.
  • Patient having distant vision 6/6 or best corrected distant vision.
Exclusion Criteria
  • 1.Tritiya & Chaturtha patalagata Timira.
  • 2.Patient with infective anterior segment disease & any other ocular pathologies like cataract, glaucoma & retinal pathologies.
  • 3.Patients who have underwent any of the ocular surgeries 4.patients suffering from any of the systemic disorders (Hypertension, diabetes,dislipidemia).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Near vision improvementat 1st day, 25th day, 45th day
Secondary Outcome Measures
NameTimeMethod
Relief in other signs & symptoms of Presbyopia1st day , 25th day , 45th day

Trial Locations

Locations (1)

Rishikul Government P.G Ayurvedic college & Hospital

🇮🇳

Hardwar, UTTARANCHAL, India

Rishikul Government P.G Ayurvedic college & Hospital
🇮🇳Hardwar, UTTARANCHAL, India
Dr Merilu Manyu
Principal investigator
7578887498
afrailiang1693@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.